In addition, they found that schizophrenia patients with specific CNR1 polymorphisms (specifically rs12720071 SNP G-allele carriers) were more vulnerable to the impact of heavy cannabis use, as they showed greater white matter volume decrease and cognitive impairment than patients without heavy cannabis use. Here, CNR1 is linked to schizophrenia.